BridgeBio Pharma, Inc.BBIONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+57.1%
5Y CAGR+30.7%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+57.1%/yr
vs +34.6%/yr prior
5Y CAGR
+30.7%/yr
Recent acceleration
Acceleration
+22.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $555.14M | +92.1% |
| 2024 | $288.93M | +91.9% |
| 2023 | $150.59M | +5.2% |
| 2022 | $143.19M | -25.5% |
| 2021 | $192.21M | +31.9% |
| 2020 | $145.68M | +54.4% |
| 2019 | $94.35M | +116.5% |
| 2018 | $43.59M | +227.7% |
| 2017 | $13.30M | - |